Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank E Jones

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Cell Biology|November 10, 2004
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperoneChristopher C Williams, June G Allison, Gregory A Vidal, et al.
The Journal of Biological Chemistry|February 7, 2012
Interaction with ErbB4 promotes hypoxia-inducible factor-1α signalingIlkka Paatero, Anne Jokilammi, Pekka T Heikkinen, et al.
Molecular Cancer|December 22, 2010
Downregulation of miR-342 is associated with tamoxifen resistant breast tumorsDiana M Cittelly, Partha M Das, Nicole S Spoelstra, et al.
ACS Omega|August 29, 2019
Identification of New Mono/Dihydroxynaphthoquinone as Lead Agents That Inhibit the Growth of Refractive and Triple-Negative Breast Cancer Cell LinesRichard Schroeder, Mary Sfondouris, Navneet Goyal, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2013
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancerJayalakshmi Sridhar, Mary E Sfondouris, Melyssa R Bratton, et al.
Oncotarget|November 28, 2014
A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumorsFarah B Rahmatpanah, Zhenyu Jia, Xin Chen, et al.
Cancer Research|August 17, 2006
Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cellsYun Zhu, Lacey L Sullivan, Sujit S Nair, et al.
Molecular Cancer Therapeutics|August 13, 2009
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistanceDoyel Mitra, Michael J Brumlik, Stella U Okamgba, et al.
The Journal of Physiology|May 6, 2016
The transcription factor NeuroD2 coordinates synaptic innervation and cell intrinsic properties to control excitability of cortical pyramidal neuronsFading Chen, Jacqueline T Moran, Yihui Zhang, et al.
American Journal of Clinical Pathology|April 23, 2008
Expression of tumor necrosis factor alpha converting enzyme in endocrine cancersTove Kirkegaard, Anjali Naresh, Vicky S Sabine, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Cell Biology|November 10, 2004
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperoneChristopher C Williams, June G Allison, Gregory A Vidal, et al.
The Journal of Biological Chemistry|February 7, 2012
Interaction with ErbB4 promotes hypoxia-inducible factor-1α signalingIlkka Paatero, Anne Jokilammi, Pekka T Heikkinen, et al.
Molecular Cancer|December 22, 2010
Downregulation of miR-342 is associated with tamoxifen resistant breast tumorsDiana M Cittelly, Partha M Das, Nicole S Spoelstra, et al.
ACS Omega|August 29, 2019
Identification of New Mono/Dihydroxynaphthoquinone as Lead Agents That Inhibit the Growth of Refractive and Triple-Negative Breast Cancer Cell LinesRichard Schroeder, Mary Sfondouris, Navneet Goyal, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2013
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancerJayalakshmi Sridhar, Mary E Sfondouris, Melyssa R Bratton, et al.
Oncotarget|November 28, 2014
A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumorsFarah B Rahmatpanah, Zhenyu Jia, Xin Chen, et al.
Cancer Research|August 17, 2006
Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cellsYun Zhu, Lacey L Sullivan, Sujit S Nair, et al.
Molecular Cancer Therapeutics|August 13, 2009
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistanceDoyel Mitra, Michael J Brumlik, Stella U Okamgba, et al.
The Journal of Physiology|May 6, 2016
The transcription factor NeuroD2 coordinates synaptic innervation and cell intrinsic properties to control excitability of cortical pyramidal neuronsFading Chen, Jacqueline T Moran, Yihui Zhang, et al.
American Journal of Clinical Pathology|April 23, 2008
Expression of tumor necrosis factor alpha converting enzyme in endocrine cancersTove Kirkegaard, Anjali Naresh, Vicky S Sabine, et al.
Pageof 5